Bone turnover across the menopause transition
- 5 April 2010
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1192 (1), 153-160
- https://doi.org/10.1111/j.1749-6632.2009.05349.x
Abstract
Accumulating evidence demonstrates increasing bone turnover and bone loss in women prior to menopause and decreases in serum estradiol levels. Increased follicle-stimulating hormone levels have been correlated with some of these peri-menopausal changes. However, decreases in gonadal inhibins of the transforming growth factor (TGF)-beta superfamily strongly correlate with increases in bone formation and resorption markers across the menopause transition and predict lumbar bone mass in peri-menopausal women, likely as a result of direct inhibin suppression of osteoblastogenesis and osteoclastogenesis. Inhibins bind specifically to cells during osteoblastogenesis and osteoclastogenesis. They can block bone morphogenetic protein (BMP)-stimulated osteoblast and osteoclast development as well as BMP-stimulated SMAD1 phosphorylation, likely via inhibin-beta-glycan sequestration of BMP Type II receptor (BMPRII). Interestingly, continuous in vivo exposure to inhibin A is anabolic and protective against gonadectomy-induced bone loss in mice, suggesting that inhibins contribute to the endocrine regulation of bone metabolism via a bimodal mechanism of action whereby cycling inhibin exposure suppresses bone turnover and continuous exposure to inhibins is anabolic.Keywords
This publication has 49 references indexed in Scilit:
- Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III ReceptorJournal of Biological Chemistry, 2008
- A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and MenJournal of Bone and Mineral Research, 2008
- Osteoclast-derived activity in the coupling of bone formation to resorptionTrends in Molecular Medicine, 2005
- Activins and Inhibins and Their SignalingAnnals of the New York Academy of Sciences, 2004
- Inhibin Is an Antagonist of Bone Morphogenetic Protein SignalingPublished by Elsevier BV ,2003
- Sex Steroids and BoneRecent Progress in Hormone Research, 2002
- Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-β SuperfamilyJournal of Biological Chemistry, 2001
- Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of OsteoporosisEndocrine Reviews, 2000
- Female Reproductive Aging Is Marked by Decreased Secretion of Dimeric InhibinJournal of Clinical Endocrinology & Metabolism, 1999
- Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male ratsEndocrinology, 1993